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Six1−/− mice were found to have apparently normal ureters in the absence of a kidney, suggesting that the growth and development of the
unbranched ureter is largely independent of the more proximal portions of the UB which differentiates into the highly branched renal collecting
system. Culture of isolated urinary tracts (from normal andmutant mice) on Transwell filters was employed to study themorphogenesis of this portion
of the urogenital system. Examination of the ureters revealed the presence of a multi-cell layered tubule with a lumen lined by cells expressing
uroplakin (a protein exclusively expressed in the epithelium of the lower urinary tract). Cultured ureters of both the wild-type and Six1 mutant
become contractile and undergo peristalsis, an activity preceded by the expression of α-smooth muscle actin (αSMA). Treatment with a number of
inhibitors of signaling molecules revealed that inhibition of PI3 kinase dissociates the developmental expression of αSMA from ureter growth and
elongation. Epidermal growth factor also perturbed smooth muscle differentiation in culture. Moreover, the peristalsis of the ureter in the absence of
the kidney in the Six1−/− mouse indicates that the development of this clinically important function of ureter (peristaltic movement of urine) is not
dependent on fluid flow through the ureter. In keeping with this, isolated ureters cultured in the absence of surrounding tissues elongate, differentiate
and undergo peristalsis when cultured on a filter and undergo branching morphogenesis when cultured in 3-dimensional extracellular matrix gels in
the presence of a conditioned medium derived from a metanephric mesenchyme (MM) cell line. In addition, ureters of Six1−/− urinary tracts (i.e.,
lacking a kidney) displayed budding structures from their proximal ends when cultured in the presence of GDNF and FGFs reminiscent of UB
budding from the wolffian duct. Taken together with the above data, this indicates that, although the distal ureter (at least early in its development)
retains some of the characteristics of the more proximal UB, the growth and differentiation (i.e., development of smooth muscle actin, peristalsis and
uroplakin expression) of the distal non-branching ureter are inherent properties of this portion of the UB, occurring independently of detectable
influences of either the undifferentiated MM (unlike the upper portion of the ureteric bud) or more differentiated metanephric kidney. Thus, the
developing distal ureter appears to be a unique anatomical structure which should no longer be considered as simply the non-branching portion of the
ureteric bud. In future studies, the ability to independently analyze and study the portion of the UB that becomes the renal collecting system and that
which becomes the ureter should facilitate distinguishing the developmental nephrome (renal ontogenome) from the ureterome.
© 2006 Elsevier Inc. All rights reserved.Keywords: Six1; Kidney; Ureter⁎ Corresponding author. University of California, San Diego, 9500 Gilman
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The mammalian kidney and urinary tract consist of a series of
interconnected epithelial tubules that function in the formation,
concentration, deposition and collection of urine in the urinary
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glomerulus through the distal convoluted tubule), the collecting
duct, renal pelvis and the ureter, arise from the reciprocal
inductive interactions of two progenitor tissues, the metanephric
mesenchyme (MM) and the epithelial ureteric bud (UB) (Davies,
2002; Dressler, 2002; Sampogna and Nigam, 2004; Shah et al.,
2004). These interactions begin with the induction of outgrowth
of the epithelial UB from the wolffian duct, in response to signals
arising from the MM. The UB invades this loose aggregate of
mesenchymal cells where, via continued inductive signals from
the MM, it will undergo multiple rounds of iterative branching
and elongation to form the tree-like structure of the renal
collecting system. Concurrently, cells within the MM, in
response to inductive signals arising from the tips of the
branchingUB, condense and aggregate at the UB tips where they
are further induced to undergo mesenchymal-to-epithelial
transition and tubulogenesis ultimately differentiating into the
nephron. Meanwhile, the more distal portion of the UB (i.e., that
which lies outside of the MM), by an as yet to be elucidated
mechanism, elongates and differentiates into the non-branched
ureter. This straight muscular tube, external to the kidney,
connects the renal pelvis to the urinary bladder via the
ureterovesical junction (UVJ) forming the conduit between the
collecting system of the kidney and the bladder.
Many developmental anomalies of the urinary tract, includ-
ing kidney aplasia, multicystic dysplastic kidney, hypoplastic
kidney, ureteropelvic junction obstruction, vesicoureteral
reflux, ectopic ureter orifice, hydronephrosis, hydroureter,
megaureter and duplex collecting system, can be attributed to
abnormalities in the development of the ureteric bud and ureter
(Kuwayama et al., 2002; Miyazaki and Ichikawa, 2003;
Miyazaki et al., 2000; Pohl et al., 2002; Shah et al., 2004).
Mutational analysis studies over the past several years have
increased our understanding of the underlying mechanism(s)
regulating the development and differentiation of the urinary
tract and have demonstrated the importance of several genes in
these processes (Hu et al., 2000; Jenkins et al., 2005; Kong et
al., 2004; Miyazaki and Ichikawa, 2003; Miyazaki et al., 2000;
Yu et al., 2002). Although most of the genes that have been
identified are thought to have a role in either the outbudding of
the UB from the wolffian duct or in UB branching
morphogenesis and development of the renal collecting system,
some have been found which affect development and
differentiation of the more distal ureter. For example, mice
deficient for uroplakin IIIa, an integral membrane protein found
on the apical surface of the epithelial lining of the ureter and
bladder (urothelium), display vesicoureteral reflux suggesting
that differentiation of the ureter is crucial to development of the
urinary tract (Hu et al., 2000). In support of this notion, sonic
hedgehog, together with bone morphogenetic protein 4
(BMP4), has also been demonstrated to modulate the timing
of differentiation of smooth muscle cells along the length of the
distal ureter (Yu et al., 2002). The reduction in smooth muscle in
the ureter of sonic hedgehog knockout mice is thought to play a
role in the development of hydroureter in these animals (Yu et
al., 2002). In another study, deletion of the regulatory subunit of
Ca2+-dependent serine/threonine phosphatase, calcineurin B(CnB), resulted in abnormal development of the renal pelvis and
ureter, leading to defective pyeloureteral peristalsis, progressive
renal obstruction and, eventually, fatal renal failure (Chang et
al., 2004). Recently, the T-box transcription factor, Tbx18, has
been implicated in the development of the ureter (Airik et al.,
2006; Mendelsohn, 2006). Deletion of Tbx18 in mice lead to an
absence of ureteral smooth muscle cells, short hydroureters, as
well as hydronephrosis and implicates this Tbx gene in the
etiology of anomalies of the kidneys and the urinary tract (Airik
et al., 2006). Despite these findings, much remains to be
elucidated concerning the mechanism(s) regulating differentia-
tion and maturation of the distal ureter.
Here, we have analyzed the development of the lower
urinary tract in wild-type and in mice in which the transcription
factor Six1 has been deleted. We have previously shown that
Six1−/− mice have defective genitourinary development includ-
ing renal agenesis (Li et al., 2003). Although the mice displayed
incomplete penetrance, ranging from the complete absence of
kidneys to a marked often asymmetrical reduction in kidney
size (Li et al., 2003), closer examination of the urogenital tract
in these knockout animals revealed that ureter development
occurs even in the absence of a kidney (with apparently normal
adrenal development and positioning as well). The continued
growth and development of the distal ureter in the absence of
the kidney indicates separation of collecting system and upper
tract development from lower tract morphogenesis (both of
which arise from the same UB). Using an in vitro model system
in which embryonic mouse urinary tracts including the kidneys,
ureters and the urogenital sinus and/or bladder are removed
from the embryos and grown in culture (Batourina et al., 2002),
the findings indicate that neither the structural formation of the
ureter (including elongation and the presence of a lumen) the
development of smooth muscle actin, or the establishment of
peristaltic activity depends on the presence or morphogenesis of
the kidney. Moreover, distal ureter development out of the
caudal UB is largely independent of the influences that regulate
the rest of UB morphogenesis during collecting system and
upper tract development.
Materials and methods
Materials
FITC-conjugated monoclonal anti-α smooth muscle actin (F3777) was
obtained from Sigma (St. Louis, MO). A monoclonal antibody that reacts
specifically with uroplakin III (AU1) was obtained from Progen Biotechnik
(Heidelberg, Germany). Recombinant growth factors [i.e., epidermal growth
factor (EGF), heparin-binding EGF (HB-EGF), transforming growth factor
alpha (TGFα)] were obtained from R&D Systems (Minneapolis, MN). The
signal transduction inhibitors SB203580, PD98059, AKT inhibitor, LY294002
and LY303511 were from Calbiochem (San Diego, CA). Fluorescent-labeled
secondary antibodies were from Jackson ImmunoResearch Laboratories (West
Grove, PA). All other chemicals and reagents, unless otherwise indicated, were
from Sigma (St. Louis, MO).
Southern blot
DNA isolated from tail-snips by incubating overnight at 55°C in lysis buffer
(50 mM KCl, 10 mM Tris–HCl, pH 8.3, 2.5 mM MgCl2, 0.1% gelatin, 0.45%
Nonidet P-40, 0.45% Tween 20 and 24 μg of proteinase K) was digested with
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to Gene Screen Plus (PerkinElmer, Wellesley, MA), DNAwas hybridized to a 5′
cDNA outside probe for Six1 (Li et al., 2003).
X-gal staining
Embryos from timed pregnant Six1+/− mice at 10.5 days of gestation (day
0.5 of gestation coincided with appearance of the vaginal plug) were removed
and frozen in OCT. Fresh frozen sections were fixed with cold formalin (4°C) for
10 min. Slides were washed with PBS (3×5 min), rinsed in distilled water and
incubated in X-gal working solution at 37°C for 24 h in a humidified chamber.
Sections were then rinsed with PBS (3×5 min) rinsed in distilled water and
counter-stained with DAPI. Following a rinse in distilled water and coverslips
were mounted using Fluoromount-G.
Organ culture
Whole embryonic kidney
Kidneys were isolated from wild-type and mutant murine embryos at days
10.5–11 of gestation, positioned on top of a Transwell filter (0.4 μm pore size)
within an individual well of a 12-well tissue culture dish and cultured for up to
5 days in DME/F12 media supplemented with 10% fetal bovine serum. The
cultures were maintained at 37°C at an atmosphere of 5% CO2 and 100%
humidity.
Whole urinary tract
The entire urogenital system (i.e., kidneys, ureters and the urogenital sinus)
from murine embryos at days 11–15 of gestation was isolated and positioned on
top of a Transwell filter (0.4 μm pore size). The Transwells were placed within
the individual wells of a 12-well tissue culture dish to which 750 μl DME/F12
media supplemented with 10% fetal bovine serum had been applied. The
cultures were maintained at 37°C at an atmosphere of 5% CO2 and 100%
humidity. In the case of inhibitor studies, stock solutions of the chemical agents
were added directly to the culture medium.
Isolated ureter
Sections of ureter from murine embryos at days 12–13 of gestation were
mechanically dissected free from the freshly isolated whole urinary tract,
positioned on top of a Transwell filter and cultured as described above.
Ureter branching
Sections of isolated ureter were suspended within 75 μl of a mixture of type I
collagen and Matrigel (Becton Dickinson, Franklin Lakes, NJ) applied to the top
of a Transwell filter within individual wells of a 24-well tissue culture dish
containing 400 μl of a metanephric mesenchyme cell-conditioned media (BSN-
CM) supplemented with 125 ng/ml GDNF, 250 ng/ml FGF1 (Qiao et al., 1999,
2001; Sakurai et al., 2001, 2005).
Isolated wolffian duct
Wolffian ducts were isolated by mechanical separation from E11 mouse
whole mesonephros. The cleaned wolffian ducts were placed on top of
Transwells filter, which were then cultured for up to 7 days within individual
wells of a 24-well tissue culture dish containing 400 μl of growth media (DME/
F12 media supplemented with 10% fetal bovine serum) with 250 ng/ml each of
GDNF, FGF1 and FGF7. Fresh metanephric mesenchyme isolated from wild-
type mice at days 10. 5–11 of gestation was placed in contact with the ectopic
UBs and cultured for up to an additional 5 days.
Microinjections
In order to visualize the lumens of the growing urinary tract, fluorescently
labeled dextran sulfate between 3 and 40 kDa was injected into the luminal space
using an Eppendorf semi-automated microinjection apparatus mounted on a
Nikon inverted microscope via pulled glass capillary needles (Meyer et al.,
2004). The fluorescently labeled urinary tract cultures were visualized using
both a Nikon dissecting microscope equipped with epifluorescence, as well as a
Zeiss LSM-510 scanning laser confocal microscope equipped with an argon/
krypton laser and oil-DIC objectives.Immunofluorescence
Whole mounts
Embryonic urinary tracts (ed12–16) cultured for up to 7 days were fixed in
4% paraformaldehyde for 60 min at RT. The fixed cultures were washed 3 times
with PBS and incubated overnight at 4°C in PBS with 0.1% Tween-20.
Specimens were blocked for 12–24 h at 4°C with 1% BSA in PBS, incubated for
2 h at RT in blocking buffer containing an FITC-conjugated anti-αSMA
monoclonal antibody (1:250) and washed 3 times in PBS.
Sections
Cultured urinary tracts were fixed in 4% paraformaldehyde and embedded in
paraffin. 5–8 μm sections were obtained, de-paraffinized and rehydrated in PBS/
0.1% Tween 20 for 1 h at RT. Specimens were incubated for 2 h at RT in
blocking buffer containing an FITC-conjugated anti-αSMA monoclonal
antibody (1:250). Sections were washed 3×15 min in PBS and coverslips
were mounted with Fluoromount-G. For localization of uroplakin III, the 5-μm
sections were exposed to heat retrieval in a microwave (3× at 700 W) in 10 mM
sodium citrate (pH 6.0). Slides were cooled, blocked with 0.5% BSA in PBS for
2 h at RT followed by a 2-h incubation in primary antibody. The specimens were
washed 3 times for 30 min in blocking buffer and then incubated for an
additional 2 h at RT in a 1:1000 dilution of fluorescently labeled secondary
antibody. Specimens were washed and mounted in Fluoromount-G. All
specimens were examined and photographed with either a Nikon Diaphot
inverted microscope or a Nikon Eclipse 80i upright microscope both equipped
with epifluorescence.
Measurements of peristalsis
Phase contrast time-lapse sequences of the contracting ureters were obtained
with a Spot RT digital camera (Diagnostic Instruments, Sterling Heights, MI)
attached to a Niakon Diaphot inverted microscope. Images were obtained every
0.1 s and measurements of the luminal diameter of the contracting ureters were
taken at the proximal and distal ends of the ureter using ImagePro Plus (Media
Cybernetics, Silver Spring, MD).Results and discussion
Utilizing in vitro culture of embryonic mouse urinary tracts
and isolated ureters (Batourina et al., 2002, 2005; Chang et al.,
2004; David et al., 2005), a detailed analysis of lower urinary
tract development in both wild-type and Six1−/− mutant mice
indicates that the growth and differentiation (i.e., development of
smooth muscle actin, peristalsis and uroplakin expression) of the
distal non-branching ureter are inherent properties of this portion
of the UB, occurring independently of obvious influences of
either the undifferentiated MM (unlike the upper portion of the
ureteric bud) or more differentiated metanephric kidney.
Six1 mutant mice, despite the absence of kidneys, have normal
appearing urogenital regions
In a previous study, genetic deletion of the transcription
factor, Six1, was found to lead to the development of a variety
of abnormalities of renal development, with many of the
animals being anephric (Li et al., 2003). In that study, mice null
for the Six1 genomic locus were generated through homologous
recombination in embryonic stem cells replacing the function-
ally conserved domains with IRES-LacZ and PGK-Neo
sequences (Li et al., 2002, 2003). As seen in Fig. 1, this results
in the loss of the wild-type 9.5 kb band and the appearance of a
4.0-kb band in Six1−/− mice, whereas heterozygous animals
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through the developing urogenital region in heterozygous
animals revealed the expression of Six1 in the aggregate of
metanephric mesenchymal cells (Fig. 1B). Examination of the
expression of a number of genes thought to be involved in
kidney development showed a reduction in the expression of
GDNF in Six1−/− animals (Li et al., 2003). Based on the X-gal
staining, this suggests that ablation of Six1 perturbs the
inductive signal (i.e., GDNF) arising from the MM thusdisrupting development of the metanephric kidney by effecting
the growth rate of the UB (Sajithlal et al., 2005). This notion is
supported not only by the finding that in mutant animals (in
which kidneys are present) there is a dramatic reduction in
kidney size (Fig. 1C), but also from the fact that cultured whole
embryonic kidneys from mutant animals grow at a much slower
rate than wild-type kidneys (Figs. 1D–G). However, the
wolffian duct (the progenitor tissue of the UB) from Six1−/−
mice retains the ability to respond to GDNF with the appearance
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UBs have the ability to induce mesenchymal differentiation
(Fig. 1J), indicating the competency of the wolffian duct and
UB to respond to and produce morphogenetic signals. Never-
theless, in spite of the absence of kidneys in Six1−/− mice, closer
examination of a large number of these animals revealed that the
ureters and primordial bladders were still found in the mutant
animals (Figs. 1K–L). Embryonic mice (ed15–ed17) from
wild-type and knock-out mice were isolated, fixed and the
urogenital regions were dissected free from surrounding tissue
and examined. Except for the absence of the metanephric
kidneys in homozygous knockout animals, the urogenital
regions from these mice appeared remarkably similar to that
from wild-type mice (Figs. 1K–L). In fact, the remaining
structures, including the ureter and bladder, as well as the
adrenal glands not only appeared morphologically indistin-
guishable on gross examination, but these structures were all
found to be in their correct anatomical position (Figs. 1K–L). In
the case of the ureter, this is particularly interesting because the
non-branched ureter is derived from the distal portion of the
ureteric bud, the proximal portion of which undergoes
branching morphogenesis within the metanephric mesenchyme
and becomes the renal collecting system. The presence of a
growing and developing ureter in the absence of its more
proximal portion suggests that its development is independent
of the growth and development of the kidney. Moreover,
because the ureter continues to grow and elongate in the
absence of the kidney, it is clear that these developmental
processes are not simply due to the anterior movement of the
kidney away from the bladder as the body axis elongates, but
rather are inherent properties of the ureter.
Isolated urinary tract (UT) from fetal mice can be cultured in
vitro
To more closely examine the development of the ureter,
whole urinary tracts (UTCs) were isolated from mouse wild-
type and mutant embryos from gestational day (ed) 12 (ed12) to
ed14 and cultured on Transwell filters in the presence of normal
growth media (Figs. 2A–F). Under these culture conditions, the
various components of the urinary tract, including the kidneys,
ureters and bladder, continued to grow and develop (Fig. 2). The
kidneys responded in a manner similar to that seen in wholeFig. 1. (A) Southern blot analyses of mouse genomic DNA in wild-type (+/+), h
demonstrated the loss of the wild-type 9.5-kb band and presence of the 4.0-kb mutant
of both bands. (B) X-gal staining of cryostat sections through the urogenital region of
enclosed by the dashed line) but not in the wolffian duct (W). Nuclei were visualize
illustrating the difference in embryonic kidney size from wild-type and Six1−/− m
photomicrographs of isolated kidneys from wild-type (D–E) and mutant (F–G) mice c
E, G Day 5 of culture. Differences in kidney size are readily visible, as is the slower
Phase contrast photomicrographs of a wolffian duct (WD) isolated from a ed10.5
metanephric mesenchyme. (H) WD cultured for 3 days in the presence of GDNF just a
WD are clearly visible (scale bar=200 μm). (I) WD after 2 days of recombination w
mesenchyme indicative of the beginnings of nephron differentiation (scale bar=200 μ
body has been highlighted (scale bar=100 μm). (K–L) Dark-field photomicrographs
and size of the structures found in this region. (K) Low magnification examination of
absence of the kidney, the ureter and adrenals appear to be found in the proper position
in Panel A; scale bar=1 mm.organ culture displaying clear increases in surface area. The
proximal UB continued to undergo branching morphogenesis
within the metanephric mesenchyme (MM), whereas the MM
appeared to undergo mesenchymal-to-epithelial transition (Fig.
2). Although the overall size of the urinary bladder increased,
the ureters displayed the most obvious structural changes
becoming increasingly convoluted as they elongated (Fig. 2). A
similar morphology was also seen in cultures of urinary tracts
from Six1−/− mutant mice (Figs. 2G and H). In this case,
however, the ureters continued to grow and elongate in the
absence of the kidney, displaying a convoluted morphology
similar to that seen in the cultures of wild-type urinary tracts.
Although the exact mechanism leading to this folding of the
developing ureter in vitro is unclear, a number of possibilities
are suggested from this culture model. For example, it is
possible that the tortuosity of the ureters is due to distal
blockage of the ureter to the bladder. However, this would seem
unlikely as this would be dependent upon flow through the
ureter, a situation that would not be expected to exist in this
culture model of urinary tract development. The more likely
possibility is that the tortuosity is the result of growth and
elongation of the ureter which occurs without the concomitant
separation of the various components of the urinary tract (i.e.,
kidney and bladder) as in the intact embryo. In vivo, the ureters
are apparently kept straight as the kidneys and bladder move
away from each other due to growth of the embryonic body
axis. This supports our earlier assertion that growth of the ureter,
particularly in length, is not in response to stretching of the
ureter as the kidneys and bladder are separated anteriorly and
posteriorly while the embryo grows but rather is an independent
and intrinsic property of the ureter. Injection of the ureters with
fluorescently labeled dextran revealed the presence of a patent
lumen, which is filled with the injected material down to the
developing bladder (Fig. 2I). In a previous study, microinjection
of fluorescently labeled dextran sulfate into the lumen of the
developing UB revealed the presence of a patent lumen from the
renal pelvis to the extreme tips of the branching UB as early as
ed13 in the rat (Meyer et al., 2004). In this study, microinjection
of fluorescently labeled dextran sulfate into the lumen of the
ureter from UTC isolated from an ed12 mouse embryo and
cultured for 4 days showed that the entire length of the urinary
tract is characterized by the presence of a patent lumen (Fig. 2I).
In addition, microinjection into the lumen of the ureter from theeterozygous (+/−) and Six1 knockout animals (−/−). Use of 5′ outside probe
band in the Six1−/−mice. Heterozygous animals are characterized by the presence
E10.5 embryos reveals expression of Six1 in the metanephric mesenchyme (MM;
d by counter-staining with DAPI. A, dorsal aorta; scale bar=20 μm. (C) Graph
ice isolated at 15.5 days of gestation (N≥3; *p≤0.001). (D–G) Dark-field
ultured for up to 5 days; scale bar=100 μm. Panels D, F Day 1 of culture. Panels
rate of growth of the mutant kidneys relative to the wild-type in culture. (H–I)
–11 Six1−/− mouse cultured in the presence of GDNF and recombined with
fter addition of metanephric mesenchyme. Ectopic ureteric buds (EUB) from the
ith metanephric mesenchyme. Comma and S-shaped bodies are present in the
m). (J) Higher magnification view of area boxed out in panel I. A comma-shaped
of urogenital regions isolated from a Six1−/− mutant mouse showing the position
the urogenital region displaying the agenesis of one of the kidneys. Despite the
; scale bar=1 mm. (L) Higher magnification examination of the area highlighted
Fig. 2. (A–H) Phase contrast photomicrographs of whole urinary tracts cultured on Transwell filters for up to 5 days. (A–B) Urinary tracts isolated from ed12 embryonic
mice. (C–D)Urinary tracts isolated fromed13 embryonicmice. (E–F)Urinary tracts isolated from ed14 embryonicmice. (G–H)Urinary tracts isolated fromed12 embryonic
Six1−/− mice. (I) Dual fluorescent micrograph of a cultured whole urinary tract isolated from a Hoxb7-GFP expressing transgenic mouse that has been injected with
fluorescently labeled dextran sulfate (red) to show the extent of lumen formation in the developing ureter. (J) Phase contrast photomicrograph of a culturedwhole urinary tract
isolated from a Six1−/−mouse merged with a fluorescent image to show the fluorescently labeled dextran (blue) staining in the lumens of the ureters (A–J, scale bar=1 mm).
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lumen in the ureter (Fig. 2J). The ureter, the renal pelvis, as well
as the branches of the UB are completely filled. In humans, theureter has been postulated to undergo a process of obstruction
followed by recanalization to form a patent lumen (Ruano-Gil et
al., 1975). In our observations of the cultured urinary tract, such
577K.T. Bush et al. / Developmental Biology 298 (2006) 571–584a process was not observed, and the ureter appeared to have a
patent lumen throughout the culture period. Although the
reasons for the observed differences are unclear, it is possible
that this is a species difference or a function of the culture
conditions. For example, in the culture preparation surrounding
tissue and structures, such as the mesonephros and developing
gonads, are removed. These tissues could conceivably represent
sources of soluble growth factors that play a supporting or
supplementary role in the development and growth of the distal
ureter, although the data clearly indicate that such factors are not
essential for ureteral growth and development in vitro. Never-
theless, movement of the dextran sulfate into the lumen of the
bladder was rarely seen, suggesting that the connection has yet
to be completed in our culture model. Because this lack of
continuity between the ureter and bladder in the cultured urinary
tract is seen in both wild-type and mutant animals, it is also
possible that the obstruction is a function of the culture systemFig. 3. (A–C) Hematoxylin and eosin stained sections of cultured murine urinary tra
tract. Lumen within the developing bladder is clearly visible. (B) Section taken throug
are visible. (C) Higher magnification examination of a section through the uret
photomicrograph of a whole urinary tract isolated from a Hoxb7-GFP expressing tra
GFP in the developing urinary tract. (F) Higher magnification examination of panel E
photomicrographs of sections through a cultured whole murine urinary tract that has band not an anatomical obstruction. In other words, the two-
dimensional nature of the culture setup on a filter may hinder
the development of a functional ureterovesicular junction, thus
limiting the ability of the fluorescent dextran sulfate to penetrate
down into the bladder.
Histological examination of the in vitro cultures revealed
several morphological changes as the urinary tract develops in
vitro (Figs. 3A–C). Within the developing kidney, the appear-
ance of the tubular portion of the kidney is apparent (Fig. 3B).
The branching UB, as well as the nascent comma- and s-shaped
bodies, are readily visible indicating that kidney morphogenesis
is progressing as expected. Sections through the forming renal
pelvis reveal the presence of an expanded lumen which extends
outward into the proximal portion of the developing ureter
(Figs. 3A and B). This lumen extends along the length of the
ureter up to its insertion site into the urogenital sinus and
forming bladder. Cross-sections through the developing uretercts. (A) Low magnification examination of a section through the whole urinary
h the developing kidney. Branching UB and comma- and early S-shaped bodies
er showing the presence of a multi-cell layered tubule. (D) Phase contrast
nsgenic mouse. (E–F) Fluorescent photomicrographs showing the expression of
, fluorescence can be seen extending into the urogenital sinus. (G–I) Fluorescent
een stained for the presence of uroplakin III (a marker of the urothelium) (green)
578 K.T. Bush et al. / Developmental Biology 298 (2006) 571–584revealed the presence of a central lumen surrounded by several
layers of cells. The forming bladder region also displayed the
presence of a lumen, although its continuity with the forming
ureter was difficult to determine (Fig. 3C).
Urinary tracts from transgenic mice that express GFP on
the Hoxb7 promoter were also cultured (Figs. 3D–F). In
these mice, GFP is expressed exclusively in the wolffian
ducts and its derivatives and it is found all along the length
of the developing ureteric tree from the tips of the
branching UB to the renal pelvis and along the ureter
(Figs. 3E and F). In fact, closer examination revealed that
the expression of GFP staining penetrated several milli-
meters into the urogenital sinus/bladder that is not stained
(Fig. 3F). When urinary tracts from these transgenic animals
were cultured, they appeared to develop in a manner similar
to that of wild-type animals (Figs. 3D–F). The cells lining
the lumen of both the bladder and ureter were examined for
their ability to express uroplakin III, a member of a family
of integral membrane proteins which are specific markers
for differentiation of the epithelial lining of the lower
urinary tract (i.e., renal pelvis, ureter, bladder and proximal
urethra), the urothelium (Deng et al., 2002; Lin et al., 1994;
Mak and Kuo, 2003; Sun et al., 1999; Wu et al., 1994,
1990; Yu et al., 1994, 1990). In paraffin sections of a
culture ed15 urinary tract, uroplakin was found to line the
lumen of the bladder, ureter and renal pelvis (Figs. 3G–I).
As expected, the staining of this protein did not extend any
further into the kidney and was absent from both the
collecting tubules and the remainder of the renal parench-
yma (Fig. 3G). Together, these data indicate that the portion
of the urinary tract derived from the initial UB (i.e., the
collecting system, renal pelvis and ureter) grows and
differentiates with a patent lumen and that the cavitation
is not dependent upon the movement of fluid through the
ureter.Fig. 4. Graphs illustrating the peristaltic contractions of the ureters in the cultured uri
of the ureters were taken at the proximal and distal ends of the ureters from a 10-s digi
diameter and the dashed vertical line indicates the initiation of contraction at the pro
proximal to distal end of the ureter in both wild-type and Six1−/− mice.Ureters become contractile in culture
As the cultures were allowed to proceed, it was found that the
ureters began to exhibit peristaltic contractions. These contrac-
tions, which are necessary for the efficient transport of urine
from the kidney to bladder and are characteristic of the
differentiated ureter (Chang et al., 2004; Santicioli and Maggi,
1998), began after 3–7 days in culture depending on the
embryonic day on which the urinary tract was isolated and
cultured. For example, if the cultures were initiated on ed12,
peristaltic contractions of the ureter were observed following
approximately 7 days of culture. If the cultures were initiated
using later stage embryos (e.g., ed14), the peristaltic contrac-
tions were seen at a much earlier stage; for ed14 embryos this
was first seen on or about day 3 of culture. Regardless of the day
of initiation, these peristaltic waves were observed to begin, as
has been described in vivo, at the more proximal end of the
ureter in the region of the renal pelvis and progressed down the
length of the ureter to the bladder (Fig. 4, Supplemental Movie
1). The peristalsic contractions were not only observed in
cultures of the urinary tracts from the Six1−/− mice which lack
kidneys (Fig. 4, Supplemental Movie 2) but were also seen in
cultured isolated ureters (Fig. 5A, Supplemental Movie 3). In
this case, portions of the developing ureters isolated from the
urinary tract and cultured independent of the kidney or bladder
also became contractile, developing peristalsic contractions
after several days in culture (Fig. 5A). As recently described,
these contractions of the cultured isolated ureter are unidirec-
tional preceding from the proximal end and are thought to be
dependent upon the expression of c-kit, a tyrosine kinase
receptor required for differentiation of the pacemaker cells of
the gut (David et al., 2005; Huizinga et al., 1995; Isozaki et al.,
1997; Vanderwinden et al., 1996; Ward et al., 1994). These
isolated portions of the non-branching ureter stalks also retain
the ability to undergo branching morphogenesis, as is seen withnary tracts of wild-type and Six1−/− mice. Measurements of the luminal diameter
tal recording of contracting ureters. Data are shown as the percent of the maximal
ximal end of the ureter. The contractile wave can be seen proceeding from the
Fig. 5. (A) Graph illustrating the peristaltic contractions which occur in isolated ureters cultured for several days. Measurements of the luminal diameter of the ureter
were taken at the proximal and distal ends of the ureters from a 10-s digital recording of the contracting ureter. Data are shown as the percent of the maximal diameter
and the dashed vertical line indicates the initiation of contraction at the proximal end of the ureter. The contractile wave can be seen proceeding from the proximal to
distal end of the ureter even in the absence of a kidney or bladder. (B–C) Phase contrast photomicrographs of an isolated ureter cultured for 7 days under conditions that
promote branching of the isolated ureteric bud (BSN-CM supplemented with 10% FCS, 125 ng/ml GDNF and 250 ng/ml FGF1). (D–F) Phase contrast
photomicrographs of ureter isolated from a wild-type mouse embryo and cultured for up to 7 days in normal growth media supplemented with 250 ng/ml each of
GDNF and FGF7 (D–E, scale bar=250 μM). (F) Higher magnification examination of budding ureter in panel E; arrows indicated budded ureter. Scale bar=100 μM.
(G–I) Phase contrast photomicrographs of whole urinary tract isolated from a Six1−/− mouse embryo and cultured for up to 7 days in normal growth media
supplemented with 250 ng/ml each of GDNF, FGF1 and FGF7. (I) Higher magnification examination of budding area in Panel H; arrows indicated budded ureter (D–
E, scale bar=250 μM).
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tissue, which is derived from the same outgrowth of the
wolffian duct as the branching UB, but develops into a straight
non-branching tube, is isolated and cultured under conditions
which promote UB branching, it forms a highly branched
structure (Fig. 5C). In addition, isolated ureters cultured on
filters in the presence of GDNF and FGF7 are induced to
undergo morphogenetic changes reminiscent of UB buddingfrom the wolffian duct (Figs. 5D–F). Similar structures are seen
on ureters of isolated urinary tracts of Six1−/− mice cultured for
up to 7 days in the presence of a combination of GDNF, FGF1
and FGF7 (Figs. 5G–I). Although these data indicate that the
distal ureter retains characteristics of its more proximal portion
(i.e., the ability to branch and bud in response to soluble
growth factor), they demonstrate that growth and differentiation
(i.e., elongation of the ureter, differentiation of a urothelium,
580 K.T. Bush et al. / Developmental Biology 298 (2006) 571–584development of smooth muscle and peristaltic contractility) of
the distal ureter are actually intrinsic properties of the distal
ureter.
The observed peristaltic contractions in the cultures of the
whole mouse urinary tract indicate that there is development of
ureteral smooth muscle in vitro. In vivo, the expression of
alpha-smooth muscle actin (αSMA), an indicator of smooth
muscle development, has been investigated in both rats andFig. 6. Fluorescent photomicrographs showing the expression of α-smooth muscle a
(green) in the urinary tract of an ed16 mouse embryo. Extensive staining can be seen
tract cultures isolated from wild-type (B) and Six1−/− mice and stained for the expre
(blue). (D–L)Whole murine urinary tracts isolated from ed12 (D­F), ed13 (G­I) and
stained for the expression of αSMA (A–C, scale bar=500 μm; D–L, scale bar=1 mmice (Yu et al., 2002). In rat embryos, no staining of αSMAwas
noted along the ureter until ed20 (Baker and Gomez, 1998). At
that time, subepithelial staining was apparent, particularly
around the distal ureter. One day after birth, the smooth muscle
coat of the ureter is well developed, although there is less
staining of the renal pelvis than of the remainder of the ureter.
By postpartum day 10, uniform staining for αSMA is seen
throughout the ureter and intrarenal collecting system with noctin (αSMA) in the developing murine urinary tract. (A) Expression of αSMA
along the length of the ureter and throughout the bladder. (B–C) Whole urinary
ssion of αSMA (green) and injected with fluorescently labeled dextran sulfate
ed14 (J­L) wild-type mice and cultured for up to 5 days. Cultures were fixed and
m).
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Gomez, 1998). In mice, αSMA has previously been shown to
be expressed in the ureter after ed16.5 (Yu et al., 2002). Staining
of sections taken through the developing murine urinary tract at
this stage of embryonic development reveals the expression of
αSMA along the entire length of the ureter and throughout the
urinary bladder (Fig. 6A). The in vitro expression of αSMAwas
analyzed in the cultured urinary tracts. When the image of a
patent lumen (microinjected with fluorescently labeled dextran
sulfate) is superimposed on an indirect immunofluorescent
image showing the distribution of smooth muscle actin in the
cultured urinary tract, the normal appearance of the ureters and
bladder is apparent with a layer of smooth muscle actin
surrounding the lumen in both wild-type and Six1−/− mice
(Figs. 6B and C). A time course series of UT cultures was
examined at various embryonic days of gestation (ed12 through
ed14). A spatial and temporal acquisition of αSMA that
parallels each additional day in culture was found (Figs. 6D-
6L). Ureters of the ed12 UT were found to express little, if any,
αSMA at the onset of culture (Fig. 6D) but following five days
of growth in culture the ureters strongly expressed αSMA (Fig.
6F). The developing bladder was also found to express αSMA
after 1–3 days in culture (Fig. 6F). However, it was only
observed in a small crescent shaped area at its posterior end
(Fig. 6F). In contrast, when the culture was begun at ed13,
αSMA was detectable in the ureters a day sooner in culture
(Figs. 6G–6I). It was also found that the staining for αSMA
occupies approximately half of the developing bladder follow-
ing 1 day of culture (Fig. 6G). If the culture was initiated at
ed14, αSMA can be found along the ureters after only 1 day in
culture and the bladder appeared to be completely positive for
this protein (Fig. 6J). Regardless of the stage of development,Fig. 7. Fluorescent photomicrographs showing the expression of αSMA in whole murin
the absence (A—Control) or presence of either 150 ng/ml epidermal growth factor (EGF)
staining is the expression pattern of GFP in these mice. Red staining shows the expre
bar=1 mm.αSMA staining was observed to occur in a descending pattern
from the renal pelvis and progressing down the ureter towards
the bladder (Fig. 6D–L). However, expression of αSMA in the
bladder did not parallel the expression pattern for this protein
seen in the ureters. At early stages of embryonic development,
only a portion of the distal bladder was positive for αSMA (Fig.
6D). After several days in culture, no further expression of
smooth muscle actin was observed (Fig. 6F). Thus, unlike the
differentiation seen with the ureters, the muscle layer of the
bladder does not appear to continue to develop in vitro.
Regulation of αSMA expression
The mechanism of αSMA regulation during ureter morpho-
genesis remains to be completely elucidated. Much of the
research on this area has focused on development of bladder
smooth muscle, in particular on the interactions between the
epithelial lining of the bladder (urothelium) and the surrounding
mesenchyme (Baskin et al., 1996, 1997, 1999, 2001; Liu et al.,
2000; Master et al., 2003; Wu et al., 1999). In particular, the
notion that cellular signals, most likely in the form of soluble
growth factors arising from the urothelium are critical to the
differentiation of the surrounding mesenchyme into smooth
muscle (Baskin et al., 1996, 1997, 1999, 2001; Liu et al., 2000;
Master et al., 2003; Wu et al., 1999). In an attempt to identify
the factors involved, cultures of whole urinary tracts were
cultured in the presence of various growth factors implicated in
smooth muscle development, as well as inhibitors of some
important cell signaling molecules. For example, the addition of
exogenous epidermal growth factor (EGF) was found to alter
the pattern of smooth muscle expression along the ureter (Fig.
7B). EGF and ligands of the EGF receptor (i.e., HB-EGF,e urinary tracts isolated from HoxB7-GFP transgenic mice cultured for 4–5 days in
(B), 150 ng/ml EGF and 500 nMAG1478 (C) or 500 nMAG1478 alone (D). Green
ssion pattern for αSMA in the cultured urinary tract cultures. Panels A–D, scale
582 K.T. Bush et al. / Developmental Biology 298 (2006) 571–584TGFα) have been implicated in the transition of smooth muscle
cells to a fibroblast phenotype (Yamanaka et al., 2001).
Treatment with other ligands of the EGFR was also found to
lead to the loss of αSMA expression along the ureter (data not
shown). Thus, not only does treatment with these growth factors
inhibit the expression of additional αSMA, but it leads to the
loss of that which has already been expressed (Fig. 7). This
effect is inhibited by the addition of AG1478, a specific
inhibitor of EGFR phosphorylation following ligand binding
(Fig. 7C), whereas treatment with AG1478 alone had no effect
on the development of αSMA expression (Fig. 7D), suggesting
that the differentiation of smooth muscle cells, as indicated by
the expression of αSMA, is negatively regulated by ligands of
the EGFR.
In addition a number of chemical inhibitors of several
signal transduction pathways that have been implicated in the
development of the kidney and urinary tract (Chiu et al.,
2002; Fisher et al., 2001; Han et al., 2004; Karihaloo et al.,
2001; Meyer et al., in press; Michael et al., 2005; Tang et al.,
2002; Watanabe and Costantini, 2004; Yuan et al., 2000) were
also examined for their potential role in the expression of
αSMA. Of these inhibitors, which included chemical agentsFig. 8. Fluorescent photomicrographs showing the expression ofαSMA in wholemuri
in the absence (A—Control) or presence of either 10 μM SB203580, an inhibitor of
inhibitor (D), 10 μMLY294002, an inhibitor of PI3 kinase (E), or 10 μMLY303511, a
in these mice. Red staining shows the expression pattern for αSMA in the cultured uthat block PI3-kinase (PI3K), MAP/ERK and Rho-kinase,
only LY294002, which interferes with PI3K-dependent
signaling was found to have any effect on the development
of αSMA (Fig. 8). Treatment of the cultures with LY294002
lead to a loss of smooth muscle actin expression along the
ureter without any apparent effect on either branching
morphogenesis of the upper UB or elongation or growth of
the ureter (Fig. 8E). In contrast, treatment with LY303511, an
inactive form of LY294002, served as a positive control and
treatment with it had little effect on the development of
smooth muscle actin along the ureter (Fig. 8F).
The results of this study add to previous work on the growth,
development and differentiation of the non-branched ureter. It
was found that ureters of the isolated urinary tract (from both
wild-type and Six1−/− mice) not only continue to grow and
elongate, but they differentiate expressing uroplakin III, a
molecule found exclusively in the epithelium of the lower
urinary tract (urothelium). Moreover, the ureters from knockout
and wild-type animals, as well as isolated cultured ureters,
develop contractility and undergo peristalsis after several days in
culture. Indirect immunofluorescence revealed the progressive
expression of smooth muscle actin in the cultures at variousne urinary tracts isolated fromHoxB7-GFP transgenicmice cultured for 4–5 days
p38 MAP kinase (B), 20 μM PD98059, an inhibitor of MEK (C), 50 μM AKT
negative control of LY294002 (F). Green staining is the expression pattern of GFP
rinary tract cultures. Panels A–F, scale bar=1 mm.
583K.T. Bush et al. / Developmental Biology 298 (2006) 571–584gestational ages, such that smooth muscle actin eventually can be
seen along the entire lower urinary tract from the renal pelvis and
around the bladder. Development of smooth muscle actin was
inhibited and reversed following treatment with soluble ligands
of the epidermal growth factor, including EGF, HB-EGF and
TGFα. This effect was blocked by addition of tyrphostin
AG1478, a specific inhibitor of signaling via the EGF receptor.
Furthermore, treatment with several chemical inhibitors of
various signal transduction pathways, including MAPK, ROCK
and PI3K, indicate a regulatory role for PI3K in the development
of ureteral smooth muscle actin expression. Thus, the findings
indicate that (1) the entire urinary tract is amenable to in vitro
culture and provides a model system for the analysis of the
regulatory mechanisms involved in the development of the
various structures; (2) the lumen formation and the development
of the peristaltic contractions characteristic of the differentiated
ureter are intrinsic properties of the ureter; and (3) the
developmental expression of αSMA along the ureter is
negatively regulated by ligands of the EGFR and influenced by
PI3 kinase-dependent signaling. Finally, because the growth and
development of the ureter is not dependent upon or influenced by
the regulatory mechanisms involved in the branching morpho-
genesis of the more proximal UB (in fact its growth and
differentiation is regulated separately from the more proximal
portions), the early embryonic distal ureter is clearly a distinct
structure which can no longer be thought of as simply the non-
branching portion of the ureteric bud. Studies such as this suggest
approaches to separately analyze the developmental nephrome
(renal ontogenome) and the ureterome, particularly with respect
to the role of the UB in renal versus ureter development.
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